Previous 10 | Next 10 |
2023-03-16 18:06:49 ET U.S. biotech company Sarepta Therapeutics ( NASDAQ: SRPT ) on Thursday said the FDA's Office of Therapeutics has determined that an advisory committee meeting will be held for SRP-9001 in advance of the May 29, 2023 regulatory action date. Share...
2023-03-16 17:52:41 ET The biotech industry is a rapidly growing sector. The sector focuses on the development and commercialization of novel therapies, drugs, and medical technologies. Biotech companies often utilize advanced scientific techniques. These include techniques such as gene edi...
2023-03-16 17:24:42 ET Gainers: Hub Cyber Security ( HUBC ) +6% . Altimmune ( ALT ) +5% . Hawaiian Holdings ( HA ) +4% . MacroGenics ( MGNX ) +3% . PENN Entertainment ( PENN ) +3% . Losers: Sarepta Therapeutics ( NASDAQ...
– Advisory committee meeting to be held in advance of target action date – Company will hold conference call today at 4:30 p.m. Eastern time Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today an...
2023-03-16 06:31:14 ET Summary The pharma/biotech subsector is undervalued by 16% relative to 11-year averages. Healthcare equipment is the less attractive subsector regarding both valuation and quality. Fast facts on PBE, a biotechnology and genomics ETF. 10 stocks cheape...
2023-03-09 08:30:00 ET Equity markets have been bruised and battered in the past 12 months, but over the past decade, stocks have performed well. That's the great thing about focusing on the long game. The U.S. market is highly likely to deliver attractive returns over periods of five years...
2023-03-08 10:51:52 ET Summary Roche has logged a few clinical successes lately, but hasn't scored the sort of big wins that change investment theses or drive lasting changes in sentiment. Fourth quarter pharmaceutical sales were fine, and Roche has a strong roster of $1B-plus/yea...
2023-03-05 11:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-04 09:00:00 ET Summary Sarepta Therapeutics recently reported their Q4 and full-year 2022 earnings with a minor miss on EPS and a solid beat on revenue. The market reacted positively moving SRPT up. The company continues to report solid growth trends for EXONDYS, VYONDYS, ...
Rare disease-focused biotech Sarepta Therapeutics ( NASDAQ: SRPT ) lost ~4% pre-market Friday after announcing a share exchange agreement with some of its convertible debt holders. Per the terms of the agreement signed on Mar. 02, Sarepta’s ( SRPT ) 1.50% convertible se...
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
2024-03-19 10:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-13 08:00:00 ET Sarepta Therapeutics (NASDAQ: SRPT) could have a serious new competitor on the horizon. According to some fresh clinical data from Regenxbio (NASDAQ: RGNX) , another biotech, the company is making headway with a gene therapy for Duchenne muscular dystr...
RBC Capital Markets upgraded REGENXBIO Inc (NASDAQ:RGNX), a company focused on developing gene therapies. Recently, REGENXBIO reported ad...